Bipolar Research Today is a free monthly online journal that collates and summarizes the latest research about Bipolar, including details on bipolar disorder, symptoms, treatment, depression, medication.

Volume 6 (2009), Issue 12 (December)

1. Psychiatric context of acute/early HIV infection. The NIMH Multisite Acute HIV Infection Study: IV.
   AIDS Behav, 13(6): 1061-7. [Abstract] [Full-text]
2. Metabolic profiling of human blood serum from treated patients with bipolar disorder employing 1H NMR spectroscopy and chemometrics.
   Anal Chem, 81(23): 9755-63. [Abstract] [Full-text]
3. Neurocognition in bipolar disorders--a closer look at comorbidities and medications.
   Eur J Pharmacol, 626(1): 87-96. [Abstract] [Full-text]
4. Antimanic efficacy of retigabine in a proposed mouse model of bipolar disorder.
   Behav Brain Res, 207(1): 78-83. [Abstract] [Full-text]
5. Empirical typology of bipolar I mood episodes.
   Br J Psychiatry, 195(6): 525-30. [Abstract] [Full-text]
6. Mania and attention-deficit/hyperactivity disorder: common symptomatology, common pathophysiology and common treatment?
   Curr Opin Psychiatry, 23(1): 1-7. [Abstract] [Full-text]
7. Health care utilization and its costs for depressed veterans with and without comorbid PTSD symptoms.
   Psychiatr Serv, 60(12): 1612-7. [Abstract] [Full-text]
8. P2RX7: A bipolar and unipolar disorder candidate susceptibility gene?
   Am J Med Genet B Neuropsychiatr Genet, 150(8): 1063-9. [Abstract] [Full-text]
9. Suggestive linkage at 9p22 in bipolar disorder weighted by alcohol abuse.
   Am J Med Genet B Neuropsychiatr Genet, 150(8): 1133-8. [Abstract] [Full-text]
10. Preliminary genome-wide association study of bipolar disorder in the Japanese population.
    Am J Med Genet B Neuropsychiatr Genet, 150(8): 1110-7. [Abstract] [Full-text]
11. A linkage search for joint panic disorder/bipolar genes.
    Am J Med Genet B Neuropsychiatr Genet, 150(8): 1139-46. [Abstract] [Full-text]
12. Maintenance electroconvulsive therapy combined with long-acting risperidone in the treatment of resistant bipolar affective disorder.
    J ECT, 25(4): 282-3. [Abstract] [Full-text]
13. Cognitive behavioural therapy for major psychiatric disorder: does it really work? A meta-analytical review of well-controlled trials.
    Psychol Med, 40(1): 9-24. [Abstract] [Full-text]
14. Intimate Partner Violence Victimization and Perpetration by Puerto Rican Women with Severe Mental Illnesses.
    Community Ment Health J. [Abstract] [Full-text]
15. Quetiapine XR efficacy and tolerability as monotherapy and as adjunctive treatment to conventional antidepressants in the acute and maintenance treatment of major depressive disorder: a review of registration trials.
    Expert Opin Pharmacother, 10(18): 3061-75. [Abstract] [Full-text]
16. Decoupling implicit measures of pleasant and unpleasant social attitudes.
    J Behav Ther Exp Psychiatry, 41(1): 24-30. [Abstract] [Full-text]
17. Role of the PACAP-PAC1-DISC1 and PACAP-PAC1-stathmin1 systems in schizophrenia and bipolar disorder: novel treatment mechanisms?
    Pharmacogenomics, 10(12): 1967-78. [Abstract] [Full-text]
18. Reliability of fMRI motor tasks in structures of the corticostriatal circuitry: implications for future studies and circuit function.
    Neuroimage, 49(2): 1282-8. [Abstract] [Full-text]
19. Effect of CACNA1C rs1006737 on neural correlates of verbal fluency in healthy individuals.
    Neuroimage, 49(2): 1831-6. [Abstract] [Full-text]
20. Lipid oxidation and peroxidation in CNS health and disease: from molecular mechanisms to therapeutic opportunities.
    Antioxid Redox Signal, 12(1): 125-69. [Abstract] [Full-text]
21. Predicting post-treatment-initiation alcohol use among patients with severe mental illness and alcohol use disorders.
    J Consult Clin Psychol, 77(6): 1147-58. [Abstract] [Full-text]
22. Principal components analysis of the hypomanic attitudes and positive predictions inventory and associations with measures of personality, cognitive style and analogue symptoms in a student sample.
    Behav Cogn Psychother, 38(1): 15-33. [Abstract] [Full-text]
23. Relationship between antiepileptic drugs and suicide attempts in patients with bipolar disorder.
    Arch Gen Psychiatry, 66(12): 1354-60. [Abstract] [Full-text]
24. Heterogeneity of DSM-IV major depressive disorder as a consequence of subthreshold bipolarity.
    Arch Gen Psychiatry, 66(12): 1341-52. [Abstract] [Full-text]
25. Novelty seeking: difference between suicidal and non-suicidal Hungarian adolescent outpatients suffering from depression.
    J Affect Disord, 120(1): 217-20. [Abstract] [Full-text]
26. A brief dyadic group based psychoeducation program improves relapse rates in recently remitted bipolar disorder: a pilot randomised controlled trial.
    J Affect Disord, 120(1): 272-6. [Abstract] [Full-text]
27. Prefrontal-temporal gray matter deficits in bipolar disorder patients with persecutory delusions.
    J Affect Disord, 120(1): 54-61. [Abstract] [Full-text]
28. The stanley neuropathology consortium integrative database: a novel, web-based tool for exploring neuropathological markers in psychiatric disorders and the biological processes associated with abnormalities of those markers.
    Neuropsychopharmacology, 35(2): 473-82. [Abstract] [Full-text]
29. A cytogenetic abnormality and rare coding variants identify ABCA13 as a candidate gene in schizophrenia, bipolar disorder, and depression.
    Am J Hum Genet, 85(6): 833-46. [Abstract] [Full-text]
30. Simultaneous genotype calling and haplotype phasing improves genotype accuracy and reduces false-positive associations for genome-wide association studies.
    Am J Hum Genet, 85(6): 847-61. [Abstract] [Full-text]
31. A Pilot Evaluation of the In SHAPE Individualized Health Promotion Intervention for Adults with Mental Illness.
    Community Ment Health J. [Abstract] [Full-text]
32. DISC1 duplication in two brothers with autism and mild mental retardation.
    Clin Genet. [Abstract] [Full-text]
33. Inhibition of long-term potentiation by valproic acid through modulation of cyclic AMP.
    Epilepsia. [Abstract] [Full-text]
34. Prevalence and correlates of depression with atypical symptoms in Hong Kong.
    Aust N Z J Psychiatry, 43(12): 1147-54. [Abstract] [Full-text]
35. Is lithium in a class of its own? A brief profile of its clinical use.
    Aust N Z J Psychiatry, 43(12): 1096-104. [Abstract] [Full-text]
36. Pediatric bipolar disorder.
    J Psychosoc Nurs Ment Health Serv, 47(12): 22-6. [Abstract] [Full-text]
37. Toxoplasma gondii antibody titers and history of suicide attempts in patients with recurrent mood disorders.
    J Nerv Ment Dis, 197(12): 905-8. [Abstract] [Full-text]
38. The quantitative assessment of motor activity in mania and schizophrenia.
    J Affect Disord, 120(1): 200-6. [Abstract] [Full-text]
39. Metabolic syndrome: a follow-up study of acute depressive inpatients.
    Eur Arch Psychiatry Clin Neurosci, 260(1): 41-9. [Abstract] [Full-text]
40. The role of FKBP5, a co-chaperone of the glucocorticoid receptor in the pathogenesis and therapy of affective and anxiety disorders.
    Psychoneuroendocrinology, 34: S186-95. [Abstract] [Full-text]
41. Lithium treatment -- moderate dose use study (LiTMUS) for bipolar disorder: rationale and design.
    Clin Trials, 6(6): 637-48. [Abstract] [Full-text]
42. Neural correlates of response inhibition in pediatric bipolar disorder and attention deficit hyperactivity disorder.
    Psychiatry Res, 181(1): 36-43. [Abstract] [Full-text]
43. Brugada syndrome unmasked by lithium.
    South Med J, 102(12): 1263-5. [Abstract] [Full-text]
44. Genetic Association Analysis of Functional Polymorphisms in Neuronal Nitric Oxide Synthase 1 Gene (NOS1) and Mood Disorders and Fluvoxamine Response in Major Depressive Disorder in the Japanese Population.
    Neuropsychobiology, 61(2): 57-63. [Abstract] [Full-text]
45. Mutation screening and assessment of the effect of genetic variations on expression and RNA editing of serotonin receptor 2C in the human brain.
    Psychiatry Clin Neurosci. [Abstract] [Full-text]
46. WS-50030 [7-{4-[3-(1H-inden-3-yl)propyl]piperazin-1-yl}-1,3-benzoxazol-2(3H)-one]: a novel dopamine D2 receptor partial agonist/serotonin reuptake inhibitor with preclinical antipsychotic-like and antidepressant-like activity.
    J Pharmacol Exp Ther, 332(1): 190-201. [Abstract] [Full-text]
47. The mononuclear phagocyte system and its cytokine inflammatory networks in schizophrenia and bipolar disorder.
    Expert Rev Neurother, 10(1): 59-76. [Abstract] [Full-text]
48. Epilepsy and bipolar disorders.
    Expert Rev Neurother, 10(1): 13-23. [Abstract] [Full-text]
49. Pathological amygdala activation during working memory performance: Evidence for a pathophysiological trait marker in bipolar affective disorder.
    Hum Brain Mapp, 31(1): 115-25. [Abstract] [Full-text]
50. Meta-analysis of the association between the monoamine oxidase-A gene and mood disorders.
    Psychiatr Genet, 20(1): 1-7. [Abstract] [Full-text]
51. Angiotensin-converting enzyme polymorphism in schizophrenia, bipolar disorders, and their first-degree relatives.
    Psychiatr Genet, 20(1): 14-9. [Abstract] [Full-text]
52. Searching susceptibility loci for bipolar disorder: a sib pair study on chromosome 12.
    Neuropsychobiology, 61(1): 10-8. [Abstract] [Full-text]
53. Weight status of children and adolescents in a telepsychiatry clinic.
    Telemed J E Health, 15(10): 970-4. [Abstract] [Full-text]
54. Unintended impacts of a Medicaid prior authorization policy on access to medications for bipolar illness.
    Med Care, 48(1): 4-9. [Abstract] [Full-text]
55. Linkage disequilibrium mapping of the chromosome 6q21-22.31 bipolar I disorder susceptibility locus.
    Am J Med Genet B Neuropsychiatr Genet, 153(1): 29-37. [Abstract] [Full-text]
56. Association study of PDE4B gene variants in Scandinavian schizophrenia and bipolar disorder multicenter case-control samples.
    Am J Med Genet B Neuropsychiatr Genet, 153(1): 86-96. [Abstract] [Full-text]
57. Positive association between the brain-derived neurotrophic factor (BDNF) gene and bipolar disorder in the Han Chinese population.
    Am J Med Genet B Neuropsychiatr Genet, 153(1): 275-9. [Abstract] [Full-text]
58. Phenotypic effects of a bipolar liability gene among individuals with major depressive disorder.
    Am J Med Genet B Neuropsychiatr Genet, 153(1): 303-9. [Abstract] [Full-text]
59. NRG1 gene in recurrent major depression: no association in a large-scale case-control association study.
    Am J Med Genet B Neuropsychiatr Genet, 153(1): 141-7. [Abstract] [Full-text]
60. An fMRI study of working memory in persons with bipolar disorder or at genetic risk for bipolar disorder.
    Am J Med Genet B Neuropsychiatr Genet, 153(1): 120-31. [Abstract] [Full-text]
61. Association analysis of the PIP4K2A gene on chromosome 10p12 and schizophrenia in the Irish study of high density schizophrenia families (ISHDSF) and the Irish case-control study of schizophrenia (ICCSS).
    Am J Med Genet B Neuropsychiatr Genet, 153(1): 323-31. [Abstract] [Full-text]
62. Suggestive evidence for linkage of ADHD features in bipolar disorder to chromosome 10p14.
    Am J Med Genet B Neuropsychiatr Genet, 153(1): 260-8. [Abstract] [Full-text]
63. T2 relaxation time abnormalities in bipolar disorder and schizophrenia.
    Magn Reson Med, 63(1): 1-8. [Abstract] [Full-text]
64. Symptoms leading to a bipolar diagnosis: a phone survey of child and adolescent psychiatrists.
    J Child Adolesc Psychopharmacol, 19(6): 641-7. [Abstract] [Full-text]
65. Psychosocial functioning and health-related quality of life in children and adolescents treated with open-label ziprasidone for bipolar mania, schizophrenia, or schizoaffective disorder.
    J Child Adolesc Psychopharmacol, 19(6): 635-40. [Abstract] [Full-text]
66. Altered arachidonic acid cascade enzymes in postmortem brain from bipolar disorder patients.
    Mol Psychiatry. [Abstract] [Full-text]
67. Advancing paternal age is associated with deficits in social and exploratory behaviors in the offspring: a mouse model.
    PLoS One, 4(12): e8456. [Abstract] [Full-text]
68. Smoking in schizophrenia: diagnostic specificity, symptom correlates, and illness severity.
    Schizophr Bull, 36(1): 173-81. [Abstract] [Full-text]
69. Cognitive impairment in schizophrenia and affective psychoses: implications for DSM-V criteria and beyond.
    Schizophr Bull, 36(1): 36-42. [Abstract] [Full-text]
70. Cognitive impairment in affective psychoses: a meta-analysis.
    Schizophr Bull, 36(1): 112-25. [Abstract] [Full-text]

© 2004-2013 Bipolar Research Today. All Rights Reserved.